ROCKET PHARMACEUTICALS, INC. (RCKT) Retained Earnings (Accumulated Deficit) USD 2014 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Rocket Pharmaceuticals, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2014 to 2024.
  • Rocket Pharmaceuticals, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$1.02 B, a 32.3% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$1.02 B -$249 M -32.3% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$959 M -$246 M -34.4% Dec 31, 2023 10-Q 2024-05-07
Q3 2023 -$900 M -$253 M -39% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$838 M -$249 M -42.2% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 -$772 M -$237 M -44.3% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 -$714 M -$222 M -45.1% Dec 31, 2022 10-K 2024-02-27
Q3 2022 -$647 M -$199 M -44.5% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 -$589 M -$192 M -48.2% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 -$535 M -$172 M -47.3% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 -$492 M -$169 M -52.4% Dec 31, 2021 10-K 2023-02-28
Q3 2021 -$448 M -$186 M -70.9% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 -$398 M -$165 M -70.7% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 -$363 M -$155 M -74.7% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 -$323 M -$140 M -76.3% Dec 31, 2020 10-K 2022-02-28
Q3 2020 -$262 M -$98.6 M -60.4% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 -$233 M -$88.8 M -61.7% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 -$208 M -$82.5 M -65.8% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 -$183 M -$77.3 M -73% Dec 31, 2019 10-K 2021-03-01
Q3 2019 -$163 M -$84.7 M -108% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 -$144 M -$81.5 M -131% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 -$125 M -$78.6 M -168% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 -$106 M -$74.5 M -238% Dec 31, 2018 10-K 2020-03-06
Q3 2018 -$78.6 M +$185 M +70.2% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 -$62.5 M +$194 M +75.6% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 -$46.7 M +$203 M +81.3% Mar 31, 2018 10-Q 2018-05-11
Q4 2017 -$31.4 M +$208 M +86.9% Dec 31, 2017 10-K 2019-03-08
Q3 2017 -$264 M -$37.6 M -16.6% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 -$256 M -$41.3 M -19.2% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 -$250 M -$43.5 M -21.1% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 -$239 M -$42.9 M -21.9% Dec 31, 2016 10-K 2018-03-07
Q3 2016 -$226 M -$38.1 M -20.3% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 -$215 M -$82.9 M -62.8% Jun 30, 2016 10-Q 2016-08-10
Q1 2016 -$206 M -$76.6 M -59.1% Mar 31, 2016 10-Q 2016-05-11
Q4 2015 -$196 M -$68 M -53.1% Dec 31, 2015 10-K 2017-03-16
Q3 2015 -$188 M Sep 30, 2015 10-Q 2015-11-12
Q2 2015 -$132 M Jun 30, 2015 10-Q 2015-08-07
Q1 2015 -$130 M Mar 31, 2015 10-Q 2015-05-14
Q4 2014 -$128 M Dec 31, 2014 10-K 2016-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.